SS reported receiving financial support from AbbVie, Amgen, Apellis, Astellas, Bayer, Biogen, Boehringer Ingelheim, Eyebiotech, Eyepoint Phamaceuticals, Iveric Bio, Janssen Pharmaceuticals, Nova Nordisk, Optos, Ocular Therapeutix, Kriya Therapeutics, OcuTerra, Roche, Stealth Biotherapeutics and Sanofi. SS is a member of the Eye editorial board. ME has no conflicts of interest.